Approval · Notice of Compliance 14830 · 2013
PHARIXIA: Notice of Compliance 14830
Issued October 18, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14830
- Date
- October 18, 2013
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Labelling Only
- Therapeutic class
- Local analgesic
- Canadian reference product
- TANTUM (Medicis Pharmaceutical Corp)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PHARIXIA | 02229777 | Marketed |
Medicinal ingredients
- BENZYDAMINE HCL 1.5 MG per ML